Menu
Not yet recruiting NCT07316257

Value of Adding T2 Mapping Routine MRI in Assessment of Knee Articular Cartilage Early Osteoarthritis

Observational Osteearthritis OA OA Knee

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: MRI.
Who it may be relevant to
Registry conditions: Osteearthritis, OA, OA Knee. Basic parameters: 20 years — 50 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Center list to be confirmed — check the primary protocol.
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

Value of Adding T2mapping Sequence to Routine MRI Protocol in Assessment of Knee Articular Cartilage in Early Osteoarthritis

Overview

This work aims at elucidating the role of MRI complementary T2 mapping in assessment of the articular knee cartilage for improving sensitivity of detection of early stage of osteoarthritis

Detailed description

Osteoarthritis (OA) is one of the most common degenerative joint diseases, affecting more than 500 million people worldwide (1), causing joint pain and stiffness, and negatively affecting quality of life . The knee is the most commonly affected joint, followed by the hand and hip (1).

It is important clinically to diagnose osteoarthritis in its early stages to prevent its inevitable progression (2) Routine MR imaging sequences used in the identification of knee osteoarthritis can assess articular cartilage morphology, but despite its accuracy for identifying deep hyaline cartilage defects which are considered irreversible cartilage degeneration with limited treatment options, it lacks sufficient sensitivity for early cartilage changes and low-grade chondral lesions which are the reversible stages for the potential alteration of the osteoarthritis progression(2).

T2 mapping of hyaline cartilage is an imaging technique for the qualitative and quantitative detection of the cartilage providing convincing color mapping and quantitative detection of the cartilage mainly regarding architecture and changes in water content, proteoglycan, and collagen matrix ultra-structure associated with early cartilage degeneration(3).

T2 mapping is a time constant describing the rate at which energy transfer occurs between water protons in a magnetic field (spin-spin interactions), leading to signal dephasing. In normal healthy articular cartilage, water protons are largely bound in place by a well-organized matrix of collagen fibers, allowing for rapid dephasing, and therefore low T2 values are seen(4). However, in osteoarthritic articular cartilage, the collagen fibers become disorganized, and there are more mobile water protons, resulting in high T2 values. (4).

Interventions

  • Device MRI
    Device that use coil to image asses the articular cartilage of the knee

Primary outcome measures

  • This work aims at elucidating the role of MRI complementary T2 mapping to measure the changes in T2 relaxation time of the articular knee cartilage in healthy group which there number will be 28 and pateints with early osteoarthritis there number 28 [Time frame: baseline]
Secondary outcome measures (1)
  • This work aims at quantitive stratification of osteoarthrtic changes and its impact on treatement [Time frame: baseline]

Eligibility criteria

Inclusion criteria

  • patients with clinical evidence of osteoarthritis

Exclusion criteria

  • • contraindications for MRI such as claustrophobia, heart pacemaker and ferromagnetic implants
  • patients in which the misaligned images or distortions due to motion artifacts made the interpretation of the MRI unreliable.
  • Patients with previous knee operation

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: Yes

Study design

Observational model
Case-crossover

Study locations

Center list to be confirmed — check the primary protocol.

Publications

  • Le J, Peng Q, Sperling K. Biochemical magnetic resonance imaging of knee articular cartilage: T1rho and T2 mapping as cartilage degeneration biomarkers. Ann N Y Acad Sci. 2016 Nov;1383(1):34-42. doi: 10.1111/nyas.13189. Epub 2016 Jul 29. PMID 27472534
  • Gao S, Peng C, Wang G, Deng C, Zhang Z, Liu X. Cartilage T2 mapping-based radiomics in knee osteoarthritis research: Status, progress and future outlook. Eur J Radiol. 2024 Dec;181:111826. doi: 10.1016/j.ejrad.2024.111826. Epub 2024 Nov 8. PMID 39522425

Identifiers

NCT: NCT07316257 · T2 mapping in osteoarthritis

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗